Sandu Pharmaceuticals informs about compliances-certificate
In compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received from MUFG Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 30th September 2025.
The above information is a part of company’s filings submitted to BSE.
